Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2012
02/21/2012CA2675025C Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof
02/21/2012CA2534585C Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
02/21/2012CA2418962C Anti-dual integrin antibodies, compositions, methods and uses
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2407680C Dendritic cell co-stimulator molecules
02/21/2012CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/21/2012CA2321934C Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
02/21/2012CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome
02/21/2012CA2230759C Chimeric animal and method for producing the same
02/16/2012WO2012021907A2 Vincristine immunoassay
02/16/2012WO2012021840A2 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
02/16/2012WO2012021786A2 Anti-hemagglutinin antibody compositions and methods of use thereof
02/16/2012WO2012021773A1 Antibodies to il-1beta and il-18, for treatment of disease
02/16/2012WO2012021512A2 Erythrocyte-binding therapeutics
02/16/2012WO2012021469A1 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
02/16/2012WO2012020622A1 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof
02/16/2012WO2012020367A1 Specific antibodies to g protein-coupled receptors and method for producing the same
02/16/2012WO2012020143A1 Improved anti-serum albumin binding variants
02/16/2012WO2012020096A1 Monomeric polypeptides comprising variant fc regions and methods of use
02/16/2012WO2012020072A1 Anti-syndecan-4 antibodies
02/16/2012WO2012020065A1 Fab-glycosylated antibodies
02/16/2012WO2012020059A1 Humanized egfr antibodies
02/16/2012WO2012020038A1 Anti-tenascin-c a2 antibodies and methods of use
02/16/2012WO2012020006A2 Anti-fap antibodies and methods of use
02/16/2012WO2012019437A1 Bladder cancer tumor marker, antibiotic and application thereof
02/16/2012WO2011116014A9 Humanized antibodies to labyrinthin and uses thereof
02/16/2012WO2011109104A3 Molecular clone of hiv-1
02/16/2012US20120042400 Rtd receptor
02/16/2012US20120041303 Phage antibodies to radiation-inducible neoantigens
02/16/2012US20120041181 Fusion proteins forming trimers
02/16/2012US20120041176 Ucp4
02/16/2012US20120040896 Compositions, methods and uses for modulation of brca 1
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
02/16/2012US20120040864 Method for Determining the Cbl-b Expression
02/16/2012US20120040452 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
02/16/2012US20120040431 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
02/16/2012US20120040402 Plasmid system for multigene expression
02/16/2012US20120040401 Method For Producing Proteins
02/16/2012US20120040397 Photo-Crosslinked Nucleic Acid Hydrogels
02/16/2012US20120040394 Microtumours
02/16/2012US20120040378 Meprobromate Immunoassay
02/16/2012US20120040375 Anti-muc1 antibody
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040338 RBM3 in Testicular Cancer Diagnostics and Prognostics
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039942 Outer membrane vesicles and uses thereof
02/16/2012US20120039923 Modified HIV-1 Envelope Proteins
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
02/16/2012US20120039912 Rspondin-3 inhibition in bone disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039908 Control of Protein Glycosylation and Compositions and Methods Relating Thereto
02/16/2012US20120039907 Polypeptides including modified constant regions
02/16/2012US20120039906 PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039896 Method for inhibiting cellular activation by insulin-like growth factor-1
02/16/2012US20120039895 Phosphorycholine conjugates and corresponding antibodies
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039892 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039878 Treatment and prophylaxis of amyloidosis
02/16/2012US20120039876 Stabilized liquid anti-rsv antibody formulations
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039873 Antibodies against monocyte chemotactic proteins
02/16/2012US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039861 Identification of extracellular form of pten that can be used to treat tumors
02/16/2012US20120039846 Hepatitis c antibodies and uses thereof
02/16/2012US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039797 Antibody Therapy
02/16/2012CA2808185A1 Antibodies to il-1.beta. and il-18, for treatment of disease
02/16/2012CA2808154A1 Monomeric polypeptides comprising variant fc regions and methods of use
02/16/2012CA2807942A1 Erythrocyte-binding therapeutics
02/16/2012CA2807664A1 Anti-hemagglutinin antibody compositions and methods of use thereof
02/16/2012CA2806640A1 Anti-tenascin-c a2 antibodies and methods of use
02/16/2012CA2806021A1 Anti-fap antibodies and methods of use
02/16/2012CA2805984A1 Fab-glycosylated antibodies
02/16/2012CA2805114A1 Anti-n3pglu amyloid beta peptide antibodies and uses thereof
02/16/2012CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/15/2012EP2418492A1 Meprobamate immunoassay
02/15/2012EP2418278A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
02/15/2012EP2418274A2 Multimeric Oxidoreductases
02/15/2012EP2418224A2 Reducing the risk of human and anti-human antibodies through V gene manipulation
02/15/2012EP2418223A2 Single-chain multivalent binding proteins with effector function
02/15/2012EP2418222A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
02/15/2012EP2418221A1 Specific antibodies to G protein-coupled receptors and method for producing the same
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1494